Pacira board rejects Gary Pace's resignation after withhold vote; plans diverse director additions

Pacira BioSciences, Inc.

At June 13 annual meeting, Dr. Gary Pace received more withhold than for votes in Class III director election.
Pace tendered resignation per majority-vote policy; independent directors unanimously rejected it.
Board engaged independent search firm to identify diverse candidates; expects to refresh board composition soon.
Pace will continue as Class III director until 2026 annual meeting or until successor elected.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.